ProShare Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
1,430
+40
+3% +$12.9K ﹤0.01% 1153
2025
Q4
$422K Buy
1,390
+193
+16% +$63.2K ﹤0.01% 1229
2025
Q3
$408K Sell
1,197
-345
-22% -$105K ﹤0.01% 1230
2025
Q2
$373K Sell
1,542
-346
-18% -$84.9K ﹤0.01% 1289
2025
Q1
$514K Sell
1,888
-212
-10% -$49.6K ﹤0.01% 1083
2024
Q4
$388K Sell
2,100
-515
-20% -$105K ﹤0.01% 1444
2024
Q3
$587K Sell
2,615
-24
-0.9% -$4.32K ﹤0.01% 1049
2024
Q2
$377K Sell
2,639
-263
-9% -$40.5K ﹤0.01% 1141
2024
Q1
$454K Buy
2,902
+217
+8% +$34.9K ﹤0.01% 1149
2023
Q4
$484K Sell
2,685
-65
-2% -$11.8K ﹤0.01% 1052
2023
Q3
$495K Buy
2,750
+76
+3% +$15K ﹤0.01% 921
2023
Q2
$477K Sell
2,674
-280
-9% -$64.5K ﹤0.01% 977
2023
Q1
$637K Sell
2,954
-1,002
-25% -$240K ﹤0.01% 829
2022
Q4
$870K Sell
3,956
-111
-3% -$20.4K ﹤0.01% 770
2022
Q3
$548K Buy
4,067
+237
+6% +$40.7K ﹤0.01% 884
2022
Q2
$620K Sell
3,830
-1,322
-26% -$207K ﹤0.01% 874
2022
Q1
$972K Sell
5,152
-1,837
-26% -$391K ﹤0.01% 934
2021
Q4
$1.89M Sell
6,989
-3,885
-36% -$1.31M ﹤0.01% 778
2021
Q3
$3.95M Buy
10,874
+1,862
+21% +$609K 0.01% 556
2021
Q2
$3.09M Buy
9,012
+2,188
+32% +$725K 0.01% 622
2021
Q1
$2.38M Sell
6,824
-475
-7% -$157K 0.01% 647
2020
Q4
$1.89M Buy
7,299
+248
+4% +$68.3K 0.01% 652
2020
Q3
$2.02M Buy
7,051
+320
+5% +$75.2K 0.01% 566
2020
Q2
$1.27M Buy
6,731
+1,153
+21% +$188K 0.01% 649
2020
Q1
$687K Sell
5,578
-3,172
-36% -$496K ﹤0.01% 668
2019
Q4
$1.45M Sell
8,750
-2,159
-20% -$359K 0.01% 692
2019
Q3
$1.34M Sell
10,909
-591
-5% -$78.5K 0.01% 679
2019
Q2
$1.43M Sell
11,500
-1,670
-13% -$212K 0.01% 660
2019
Q1
$1.74M Buy
13,170
+362
+3% +$48.8K 0.01% 629
2018
Q4
$1.8M Sell
12,808
-2,401
-16% -$318K 0.01% 591
2018
Q3
$2.62M Sell
15,209
-371
-2% -$62.4K 0.02% 551
2018
Q2
$2.4M Buy
15,580
+2,589
+20% +$462K 0.02% 585
2018
Q1
$2.18M Sell
12,991
-979
-7% -$133K 0.01% 600
2017
Q4
$1.36M Buy
13,970
+1,411
+11% +$129K 0.01% 729
2017
Q3
$1.3M Buy
12,559
+2,441
+24% +$182K 0.01% 673
2017
Q2
$455K Buy
10,118
+246
+2% +$9.69K ﹤0.01% 988
2017
Q1
$361K Buy
9,872
+2,918
+42% +$106K ﹤0.01% 1158
2016
Q4
$211K Buy
+6,954
New +$219K ﹤0.01% 1571

Other funds holding ONC